Prolife Indust. (PROLIFE)

Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

At ₹72.25, Prolife Indust. is a tiny ₹25 crore player in dyes and pigments. Graham would remind me that a small market cap means limited liquidity and greater fragility. The first red flag is earnings quality: profit growth has collapsed 60.27% despite sales rising 7.76%. That tells me margins are under severe pressure. Latest quarter sales of ₹29 crore produced only ₹1 crore net profit, a roughly 3.4% margin. The P/E of 10.22 flatters the stock because the 'E' is depressed; I don't pay a multiple to a cyclical trough unless I understand the cycle. Piotroski F-Score of 4/9 confirms weak financial health and poor operating efficiency. ROCE of 14.35% is respectable, but with no debt/equity or book value disclosed, I cannot judge leverage or downside protection. Promoter holding at 73.74% is a positive—it aligns owners with minority holders, though it also reduces floating stock and can exaggerate price swings. The 52-week range of ₹56.05 to ₹142.50 shows this is a volatile, cyclical business, not a steady compounder. I need a margin of safety. At current price, the market is pricing in a bounce if the cycle turns, and PEG of 1.32 is not compelling given negative profit momentum. I would not call this a wonderful business at a fair price; it is more likely a cyclical at perhaps an interesting price. I would wait for evidence of margin stabilization, a better F-score, and a clearer balance sheet before committing capital. In Mr. Market's terms, this is in the 'too hard' pile for now.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer